Susan Boehnke
Family · Houston, TXNPI 1033692843
Payments from drug & device makers
Across 65 payments — averaging $46.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$448
- AbbVie$170
- AstraZeneca$169
- Astellas Pharma US Inc$145
- Inspire Medical Systems, Inc.$132
- Johnson & Johnson$126
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,02999%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 6 | $448 |
| AbbVie | 4 | $170 |
| AstraZeneca | 3 | $169 |
| Astellas Pharma US Inc | 2 | $145 |
| Inspire Medical Systems, Inc. | 1 | $132 |
| Johnson & Johnson(2 entities) | 6 | $126 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $124 |
| Kyowa Kirin, Inc. | 1 | $123 |
| Corcept Therapeutics | 1 | $123 |
| Celltrion USA Inc. | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $117 |
| Phathom Pharmaceuticals, Inc. | 1 | $113 |
| Teva Pharmaceuticals USA, Inc. | 1 | $110 |
| Genentech USA, Inc. | 1 | $106 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| Biogen | 1 | $69 |
| Lilly USA, LLC | 3 | $62 |
| Pfizer | 3 | $58 |
| Melinta Therapeutics, LLC | 1 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Sobi, Inc | 2 | $47 |
| Rigel Pharmaceuticals, Inc. | 2 | $46 |
| Novartis | 2 | $45 |
| Merck | 2 | $40 |
| Incyte Corporation | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Braeburn Inc. | 1 | $26 |
| Deciphera Pharmaceuticals Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| AVEO Pharmaceuticals, Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Legend Biotech USA Inc. | 1 | $18 |
| Pharmaessentia USA Corporation | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $16 |
| GSK | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,049 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 22 | $325 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 12 | $135 |
Paid to pharmacies, not to this prescriber.
Other family in Houston
- Lashonda CraneHouston$3.4M
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- David WeirDallas$959K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.